OPEN END TURBO LONG - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME3HKV3

Real-time Bid/Ask 07:06:09 2024-05-29 EDT
7.18 EUR / 7.47 EUR -1.28% Intraday chart for OPEN END TURBO LONG - BECTON DICKINSON AND CO.
Current month-11.67%
1 month-9.18%
Date Price Change
24-05-29 7.23 -2.56%
24-05-28 7.42 -2.50%
24-05-27 7.61 -0.13%
24-05-24 7.62 -1.80%
24-05-23 7.76 -5.48%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 06:27 am

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME3HKV
ISINDE000ME3HKV3
Date issued 2023-11-13
Strike 146.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 8.6
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 9.69
Lowest since issue 7.23
Spread 0.23
Spread %3.08%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
226.8 USD
Average target price
279 USD
Spread / Average Target
+23.01%
Consensus